Neoplasia — AIIMS PG Previous Year Questions
24 solved PYQs · 2014–2025 · Pathology
- Solved PYQs
- 24
- Years covered
- 2014–2025
- Avg / year
- ~3
- Subject
- Pathology
How many AIIMS PG questions come from Neoplasia?
Neoplasia has contributed 24 questions to AIIMS Postgraduate Entrance papers between 2014 and 2025 — an average of about 3 questions a year. That count is measured from EByAi’s bank of 12,215 AIIMS PG questions, not estimated from a syllabus. Every one of the 24 questions carries a written, step-by-step solution, and each is tagged to Neoplasia within Pathology, so you can drill this chapter across every year at once instead of hunting through paper PDFs. Practising a chapter’s full PYQ history is the fastest way to learn the patterns examiners reuse.
Sample Neoplasia questions from real AIIMS PG papers
These are 5 real questions from the bank — exactly as asked, with the answer one tap away. All 24 Neoplasia questions (with full written solutions) are available in practice.
Question 1 · AIIMS PG 2025
Which of the following malignancies is unrelated to obesity?- (A)Pancreas
- (B)Stomach
- (C)Meningioma
- (D)Multiple myeloma
Show answerAnswer
Answer: (D) Multiple myelomaQuestion 2 · AIIMS PG 2025
Which of the following is wrongly matched with its classification?- (A)Boston classification - Colon preparation for colonoscopy
- (B)Mannheim classification - Chronic pancreatitis
- (C)Miami classification - Parathyroid adenoma and hyperplasia differentiation
- (D)LA classification - Achalasia
Show answerAnswer
Answer: (D) LA classification - AchalasiaQuestion 3 · AIIMS PG 2024
In which type of lung carcinoma is the p53 mutation most commonly observed?- (A)Adenocarcinoma
- (B)Squamous cell carcinoma (SCC)
- (C)Large cell carcinoma
- (D)Small cell carcinoma
Show answerAnswer
Answer: (B) Squamous cell carcinoma (SCC)Question 4 · AIIMS PG 2024
Which is an intranuclear immunohistochemistry marker for neuroendocrine tumors?- (A)NCAM1/CD56
- (B)Chromogranin
- (C)Synaptophysin
- (D)INSM
Show answerAnswer
Answer: (D) INSMQuestion 5 · AIIMS PG 2024
ER positivity is used as which of the following in the context of breast carcinoma?- (A)Treatment option
- (B)Prognostic marker
- (C)Molecular marker
- (D)Diagnostic marker
Show answerAnswer
Answer: (B) Prognostic marker
Neoplasia questions by year
| Year | Questions | Share of chapter questions |
|---|---|---|
| 2025 | 4 | |
| 2024 | 3 | |
| 2023 | 7 | |
| 2022 | 4 | |
| 2021 | 2 | |
| 2019 | 1 | |
| 2017 | 1 | |
| 2015 | 1 | |
| 2014 | 1 |
Practise these 24 questions with solutions
Free to start — 25 past-year questions a day with full written solutions, no card needed.
Start Neoplasia practice freeFAQs
How many AIIMS PG questions have been asked from Neoplasia?
EByAi's bank holds 24 real AIIMS PG questions from Neoplasia, asked between 2014 and 2025 — about 3 per year on average. Every count is measured from actual papers, not estimated.
Is Neoplasia important for AIIMS PG?
24 questions over 9 papers make Neoplasia a steady-weightage chapter in AIIMS PG Pathology. The year-wise table above shows exactly how often it appears.
Can I solve Neoplasia PYQs online for free?
Yes. EByAi lets you solve AIIMS PG past-year questions in the browser with written solutions — free daily practice, no card needed.